Fran Schulz Insider Profile
4 Followers
Fran Schulz, Director at FocalTherics, holds 15.10K shares in FocalTherics (Ticker: FOCL), holds ― shares in Senti Biosciences (Ticker: SNTI). Most recently, Fran Schulz Bought ― shares of FocalTherics on Aug 17, 2026 for an estimated value of $47.50K.
Fran Schulz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Fran Schulz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Fran Schulz
Fran Schulz's Trading History
FocalTherics
Aug 17, 2026
Director
Informative Buy
47.50K
$63.57K
Senti Biosciences
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Fran Schulz's performance on stock
You May Also Like
Fran Schulz insider profile FAQ
What is the percentage of profitable transactions made by Fran Schulz?
The percentage of profitable transactions made by Fran Schulz is ―.
What is the average return per transaction made by Fran Schulz?
The average return per transaction made by Fran Schulz is ―.
What stocks does Fran Schulz hold?
Fran Schulz holds: FOCL, SNTI stocks.
What was Fran Schulz’s latest transaction?
Fran Schulz latest transaction was an Informative Buy of $47.50K.
What was Fran Schulz's most profitable transaction?
Fran Schulz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Fran Schulz's role in FocalTherics?
Fran Schulz's role in FocalTherics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.